A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Clinical trial NCT07243171 · RECRUITING
Trial details
- NCT number
- NCT07243171
- Sponsor
- Hangzhou Sciwind Biosciences Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-18
- Primary completion
- 2026-08-03
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.